2 months ago
PRAX
AnalystsRudy LiRudy Li's Stock Forecasts
AnalystsRudy Li
Sectors:
Industries:
Analyst Ranking
Top 4%
#190 out of 5156 analysts
Average Return
+99.09%
Win Rate
82%23 out of 28
Risk vs Reward
Poor
Good
Rudy Li's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Praxis Precision Medicines IncPRAX | +606.90% | $38.09 | $269.26 | 2025-05-06 - 2025-12-18 | Strong Buy |
Alto Neuroscience IncANRO | +385.04% | $4.01 | $19.45 | 2025-09-28 - 2025-12-18 | Strong Buy |
Praxis Precision Medicines IncPRAX | +381.17% | $55.96 | $269.26 | 2025-07-28 - 2025-12-18 | Strong Buy |
Stoke Therapeutics IncSTOK | +286.56% | $8.26 | $31.93 | 2025-03-18 - 2025-12-18 | Strong Buy |
Stoke Therapeutics IncSTOK | +243.33% | $9.30 | $31.93 | 2025-02-18 - 2025-12-18 | Strong Buy |
Rudy Li Analyst Color
Get additional color on Rudy Li's coverage of popular stocks
Rudy Li's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Praxis Precision Medicines IncPRAX | 3 | Strong Buy | $330.00 | +22.56% | Maintains | 2 months ago |
Xenon Pharmaceuticals IncXENE | 4 | Strong Buy | $55.00 | +27.23% | Maintains | 2 months ago |
Immunic IncIMUX | 1 | Strong Buy | $3.00 | +429.10% | Initiates Coverage On | 3 months ago |
Alto Neuroscience IncANRO | 1 | Strong Buy | $15.00 | -22.88% | Initiates Coverage On | 3 months ago |
Reviva Pharmaceuticals Holdings IncRVPH | 1 | Strong Buy | $2.00 | +241.88% | Initiates Coverage On | 3 months ago |
Prothena Corp Public Ltd CoPRTA | 7 | Strong Buy | $18.00 | +91.90% | Maintains | 4 months ago |
Stoke Therapeutics IncSTOK | 4 | Strong Buy | $24.00 | -24.84% | Maintains | 4 months ago |
Centessa Pharmaceuticals PLCCNTA | 3 | Strong Buy | $30.00 | +20.72% | Maintains | 4 months ago |
Mind Medicine IncMNMD | 4 | Strong Buy | $20.00 | +59.49% | Maintains | 5 months ago |
Bright Minds Biosciences IncDRUG | 2 | Strong Buy | $80.00 | N/A | Maintains | 7 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.